07 Oct 2019
New oral drug, levoketoconazole, could be an effective treatment option for Cushing’s syndrome, according to results from a phase III clinical trial reported in The Lancet Diabetes and Endocrinology.
Call for nominations for Awards Committee Chair
30 Oct 2024
James M Tanner Award - 2025 nominations open
30 Oct 2024
Would you like to host the BSPED annual meeting?
21 Oct 2024